The present invention relates to the field of fluid transfer devices. More particularly, the invention relates to a connector section for use in contamination-free transfer of a hazardous drug from one container to another.
Medical and pharmacological personnel that are involved in the preparation and administration of hazardous drugs suffer the risk of being exposed to drugs and to their vapors, which may escape to the surroundings. As referred to herein, a “hazardous drug” is any injectable material the contact with which, or with the vapors of which, may constitute a health hazard. Illustrative and non-limitative examples of such drugs include, inter alia, cytotoxins, antiviral drugs, chemotherapy drugs, antibiotics, and radiopharmaceuticals, such as herceptin, cisplatinum, fluorouracil, leucovorin, taxol, metatroxat, gemzar, cyclophosphamide, cytoxan, and neosar, or a combination thereof, in a liquid, solid, or gaseous state.
Hazardous drugs in liquid or powder form are contained within vials, and are typically prepared in a separate room by pharmacists provided with protective clothing, a mouth mask, and a laminar flow safety cabinet. A syringe provided with a cannula, i.e. a hollow needle, is used for transferring the drug from a vial. After being prepared, the hazardous drug is added to a solution contained in a bag which is intended for parenteral administration, such as a saline solution intended for intravenous administration.
Since hazardous drugs are toxic, direct bodily contact thereto, or exposure to even micro-quantities of the drug vapors, considerably increases the risk of developing health fatalities such as skin cancer, leukemia, liver damage, malformation, miscarriage and premature birth. Such exposure can take place when a drug containing receptacle, such as a vial, bottle, syringe, and intravenous bag, is subjected to overpressure, resulting in the leakage of fluid or air contaminated by the hazardous drug to the surroundings. Exposure to a hazardous drug also results from a drug solution remaining on a needle tip, on a vial or intravenous bag seal, or by the accidental puncturing of the skin by the needle tip. Additionally, through the same routes of exposure, microbial contaminants from the environment can be transferred into the drug and fluids; thus eliminating the sterility with possibly fatal consequences.
U.S. Pat. No. 8,196,614 to the applicant of the present invention describes closed system liquid transfer systems designed to provide contamination-free transfer of hazardous drugs. The basic innovation in this patent is the provision of two separate channels—one for air and the other for liquid—that allow the differences in pressure within the system to be equalized within the closed system when liquid is transferred from one component, e.g. a syringe, to another component e.g. a drug vial, IV bag, or IV line.
As shown in
The double membrane seal actuator 130 comprises a proximal disc shaped membrane 142 having a rectangular cross-section and a distal double disc shaped membrane 143 having a T-shaped cross-section with a rectangular proximal portion 144 and a distal portion 147 disposed radially inwards with respect to proximal portion 144. Membranes 142 and 143 are seated within casing 137, while distal portion 147 protrudes distally from casing 137. Resilient elongated arms 133 and 134 having equal length are substantially longitudinally disposed, being attached at connection points 161′ and 162′, respectively, to casing 137. Arms 33 and 34 terminate with distal enlarged elements 161 and 162, respectively. The resilient arms 133 and 134 are designed such that, if not prevented from doing so, the distance between enlarged elements 161 and 162 is larger than the interior diameter of body 128 of connector section 25. Enlarged elements 161 and 162 are configured to be received in, and engaged by, shoulder portion 129 when actuator 130 is disposed in a first (distal) position.
Conduits 46 and 48 distally extend from needle holder 115, piercing membrane 142 of actuator 130. The distal ends of conduits 46 and 48 have sharp pointed ends 46a and 48a, respectively, and are further provided with apertures 111 and 112, respectively, through which fluid is transferred during a fluid transfer operation. The proximal end of air conduit 46 extends within the interior of hollow piston rod 30 and the proximal end of liquid conduit 48 terminates at or slightly proximally from cap 113 of connector section 25, so that the liquid conduit will be in fluid communication with the interior of the liquid chamber of syringe 27. When actuator 130 is in the first (distal) position (as shown in
As said, connector section 25 is adapted to be releasably coupled to another fluid transfer component, which can be any fluid container with a standard connector such as a vial adapter connected to a drug vial, a spike adapter inserted into an intravenous bag, or an intravenous line to produce a “fluid transfer assembly”, through which a fluid is transferred from the fluid transfer component to the syringe or vice versa. When, for example the proximal membrane enclosure of a vial connector is inserted into opening 126 at the distal end of connector 25, membrane 143 in the connector and a membrane at the proximal end of the vial adapter are pushed together forming a double membrane seal. If the connector and vial adapter continue to be pushed together, double membrane seal actuator 130 moves upwards inside body 128 of the connector and the pointed ends 46a and 48a of the conduits are pushed through membrane 143 and the membrane in the vial adapter establishing air and liquid channels between the syringe and drug vial via connector section 25 and the vial adapter. With this arrangement two-way transfer of fluids is accomplished by means of a pressure equalization arrangement in which the same volume of the hazardous drug and air are exchanged internally within the fluid transfer assembly.
Since filing U.S. Pat. No. 8,196,614, the applicant has filed several patent applications directed to improvements of the original design of most of the components of the apparatus. One such patent application WO 2014/122643 inter alfa describes changes to the apparatus designed to prevent accidental fluid communication between the air and fluid channels by means of the addition of a filter in the air channel and/or a sleeve through which the tips of the needles slide and also a new design for a vial adapter.
One component in particular that has been the subject of intensive development is the connector section that connects between two components of a drug transfer system, e.g. a syringe and a vial adapter. In particular emphasis has been placed on improved designs of the actuator that houses the septum or membrane. Actuators having various designs and containing either one or two septa have been described, for example in Israeli Patent Application IL237788.
As can be seen in exploded view of
In an alternative embodiment the septum, shaped as described above can be forced into the circular opening at the bottom of the bottom section 702b from below and, when the flange snaps onto annular ledge 702c the upper section 702a of the body is pushed into the lower section 702b to hold the septum in place. In another embodiment, the upper and middle sections of the septum can have the same diameter that is at least as large as the diameter of annular ledge 702c. In this embodiment the septum is forced into the lower section 702b from the bottom. Because of the flexibility of the material of which the septum is made the upper part of the septum is at first compressed to enter the lower section of the holder and then expands to fill the space on top of ledge 702c.
Two bores 710 that function in the same manner as the seat of a needle valve are created part of the way through the height of the middle part of septum 708. The lowest part of septum 708 has a diameter that matches that of the septum in the fluid transfer component, e.g. vial adaptor, to which it will be connected. Note that in
A septum holder 700 is located inside of cylindrical body 718 of the connector section. As shown, the distal ends of needles 716, 714 are inserted into bores 710 in septum 708. The diameters of bores 710 are smaller than the outer diameter of the shafts of the needles and therefore the resilient material of which the septum is manufactured pushes radially against the shaft of the needle sealing the ports 724. When not connected to another element of the liquid transfer system the distal enlarged elements 706 of arms 704 are engaged in the shoulder portion 720 at the distal end of body 718. As shown in
Connection of the syringe connector to a fluid transfer component, e.g. a vial adaptor, a spike adaptor for connection to an IV bag, or a connector for connection to an IV line, is accomplished in the same manner as described herein above. When the septum of the fluid transfer component is pushed against the bottom of septum 708, septum holder 700 begins to move upwards inside body 718 and the tips of the needles begin to exit bores 710 penetrate the solid material of septum 708. The tips of the needles pass through septum 708 and the septum of the fluid transfer component as holder 700 continues to be pushed upwards, thereby establishing air and liquid channels between the element of the liquid transfer system attached to the fluid transfer component and the proximal air chamber and distal liquid chamber in the syringe. When the fluid transfer component is pulled downward to separate it from the connector section, septum holder 700 moves downwards inside body 718 and the tips of the needles are pulled through the solid material of septum 708 and reenter bores 710.
All embodiments of existing connector sections known to the inventor of the present invention, including those that he has invented and those found in other publications, for example U.S. Pat. No. 8,122,923, comprise either one or two septa.
It is a purpose of the present invention to provide a connector section that does not comprise any septa.
Further purposes and advantages of this invention will appear as the description proceeds.
In a first aspect the invention is a locking element for a connector configured to connect two components of a fluid transfer system. The locking element comprises:
Embodiments of the locking element comprise two bores through the inset.
In a second aspect the invention is a connector configured to connect two components of a fluid transfer system. The connector comprises:
Embodiments of the connector of the invention comprise two hollow needles and two bores through the inset.
Embodiments of the connector of the invention comprise one hollow needle and one bore through the inset.
Embodiments of the connector of the invention comprise one hollow needle and two bores through the inset.
In embodiments of the connector of the invention the hollow needles may have openings near their pointed distal tips configured to allow passage of fluid between the interiors and exteriors of the needles.
In embodiments of the connector of the invention, when the connector is not connected to a second component of a fluid transfer system, the locking element is at the distal end of the cylindrical body of the connector, the distal enlarged elements of the elongated flexible arms of the locking element are fit into shoulder portions at the open lower end of the cylindrical body of the connector, and the tips of the needles are located in the bores in the insert, whereupon the openings in the sides of the needles are blocked by the interior walls of the bores thereby completely isolating the needles from each other and the outside environment preventing passage of fluid between the interiors and exteriors of the needles and exchange of fluid with the surroundings.
In embodiments of the connector of the invention, when the connector is connected to a first component of a fluid transfer system and to a second component of a fluid transfer system that comprises a septum that seals the proximal end of the second component, the septum at the top of the second component is pressed tightly against the annular disc at the distal end of the locking element, the distal enlarged elements of the elongated flexible arms of the locking element are no longer in the shoulder portions at the distal end of the connector but are fit into recesses in the second component locking the locking element and second component together, the locking element is located at or near the proximal end of the interior of the cylindrical body of the connector, and the tips of the needles are pushed out of the bores in the insert of the locking element and through the septum that seals the proximal end of the second component, whereupon the openings in the sides of the needles are no longer blocked by the interior walls of the bores thereby providing continuous fluid channels between the first component and the second component via the interiors of the needles.
All the above and other characteristics and advantages of the invention will be further understood through the following illustrative and non-limitative description of embodiments thereof, with reference to the appended drawings.
The invention is a locking element for a connector configured to connect two components of a fluid transfer system and a connector that comprises the locking element. The connector works on the same principle as that in connectors previously invented by the inventor examples of which are connector 25 shown in
The designations “upper” and “lower” used herein are of course relative and are used without reference to the orientation of components in the figures but with reference to how the components would normally be oriented during use.
An insert 206 made of resilient material, such as, for instance, silicon or soft PVC, is inserted into channel 204. Insert 206 has two bores 210 and 212 passing through it, which form sleeves through which needles acting as liquid and air channels respectively pass. The insert 206 may, in one embodiment of the invention, be kept in place by friction created by the contact of its outer surface with the inner surface channel 204 or by plastic teeth (not shown) that extend from the channel 204. The friction can be obtained simply by providing an outer diameter of insert 206 that is greater than the diameter of the inner surface of channel 204. Thus, the resilient material of which insert 206 is made is compressed and pushes back toward the inner surface of channel 204. It is also possible to provide a roughening of the outer surface of insert 206, or to provide anchoring elements on either or both surfaces.
Also see in
When connector 250 is not connected to a second component of a fluid transfer apparatus, as shown in
Referring to
As the locking element 200 and longitudinal extension 302 are pushed up into the interior of the body 252 the tips of needles 260 and 262 are forced out of the bores 210 and 212 in insert 206 and eventually through septum 304. When this happens the openings 266 near the tips of needles 260 and 262 are unblocked and the needles enter liquid channel 308 and air channel 310 in the vial adapter, thereby opening continuous separate liquid and air channels between a drug vial connected to vial adapter 300 to a syringe connected to connector 250.
After the fluid transfer process has taken place connector 250 and drug vial 300 can be separated by pulling them apart in an axial direction. As this is done locking element 200 moves downwards inside the body of connector 250 until the enlarged elements 216 are able to spring back into the shoulder portions 258 at the end of connector 250 and exit the recesses 306 in the longitudinal extension 302 thereby unlocking the vial adapter from the connector. As locking element 200 moves downwards inside the body of connector 250, needles 260 and 262 are pulled upwards through the septum 304 at the top of the vial adapter and into the bores 210 and 212 in insert 206; thereby sealing openings 266 near the tips of the needles. As the needles are pulled through self-sealing septum 304 in the vial adapter, the tips of the needles are wiped clean leaving the external surfaces of both connector and vial adapter clean of drug residue.
Many different embodiments of the connector of the invention can be produced. For example
Luer lock adapter 450 is a product produced by the applicant of the present application to connect to infusion tubing. The features of luer lock adapter 450 that are relevant to the present invention are self-sealing septum 452, liquid channel 454, recesses 456 located near the septum and a trigger-like locking mechanism 458.
In this embodiment connector 400 is very similar in structure to connector 250 but has only one hollow needle 402 that functions as a liquid conduit. Connector 400 comprises a locking element 420 that is very similar in structure to that of locking element 200, including having an annular disc 404 at its end facing the open end of the connector. When not connected to another component, as shown in
Referring now to
The fact that the locking element of the present connector does not have a septum at its distal end as is present in all prior art septum holders and connectors that contain them provides the locking element with the following important advantages over the prior art:
The applicant has performed tests to compare connectors comprising the locking element of the invention with prior art connectors that form a double septum seal. The results of these comparison tests show no difference in safety and leak prevention performance.
Although embodiments of the invention have been described by way of illustration, it will be understood that the invention may be carried out with many variations, modifications, and adaptations, without exceeding the scope of the claims.
Number | Date | Country | Kind |
---|---|---|---|
243108 | Dec 2015 | IL | national |
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/IL2016/051357 | 12/20/2016 | WO | 00 |
Publishing Document | Publishing Date | Country | Kind |
---|---|---|---|
WO2017/109776 | 6/29/2017 | WO | A |
Number | Name | Date | Kind |
---|---|---|---|
4564054 | Gustaysson | Jan 1986 | A |
5060704 | Rohrbough | Oct 1991 | A |
6070623 | Aneas | Jun 2000 | A |
6258078 | Thilly | Jul 2001 | B1 |
6378714 | Jansen et al. | Apr 2002 | B1 |
8122923 | Kraus | Feb 2012 | B2 |
8196614 | Kriheli | Jun 2012 | B2 |
8267127 | Kriheli | Sep 2012 | B2 |
9381135 | Reynolds et al. | Jul 2016 | B2 |
10376654 | Sanders et al. | Aug 2019 | B2 |
10596068 | Okiyama et al. | Mar 2020 | B2 |
20060079834 | Tennican | Apr 2006 | A1 |
20060259004 | Connell | Nov 2006 | A1 |
20100241088 | Ranalletta | Sep 2010 | A1 |
20130066293 | Garfield | Mar 2013 | A1 |
20140020792 | Kraus | Jan 2014 | A1 |
20140181320 | Farkas | Jun 2014 | A1 |
Number | Date | Country |
---|---|---|
102784058 | Nov 2012 | CN |
103501751 | Jan 2014 | CN |
237788 | Sep 2016 | IL |
S 60-501294 | Aug 1985 | JP |
2001-505083 | Apr 2001 | JP |
2001-508680 | Jul 2001 | JP |
2003-511212 | Mar 2003 | JP |
2012192047 | Oct 2012 | JP |
0128489 | Apr 2001 | WO |
2014122643 | Aug 2014 | WO |
2014181320 | Nov 2014 | WO |
WO-2014181320 | Nov 2014 | WO |
2015108495 | Jul 2015 | WO |
2015164365 | Oct 2015 | WO |
2015166993 | Nov 2015 | WO |
2016042544 | Mar 2016 | WO |
2016147178 | Sep 2016 | WO |
2016199133 | Dec 2016 | WO |
2017183031 | Oct 2017 | WO |
Entry |
---|
International Preliminary Report on Patentability for PCT/IL2016/051357—corrected version, dated May 31, 2018—20 pages. |
International Search Report for PCT/IL2016/051357, dated Mar. 21, 2017—10 pages. |
Written Opinion of the International Searching Authority for PCT/IL2016/051357, dated Mar. 21, 2017—6 pages. |
Office action from Chinese patent office in a counterpart foreign application—Chinese Patent Application No. 201680081454.3—dated Jul. 22, 2020 (7 pages); corresponding search report (3 pages); machine English translation of office action (5 pages). |
Communication and Supplementary European Search Report for EP 16 87 7898—a counterpart foreign application—dated Jul. 12, 2019; 7 pages. |
Office Action from corresponding Japanese Patent Application No. 2018-532571, dated Jan. 19, 2021 (2 pages—English translation—2 pages). |
Number | Date | Country | |
---|---|---|---|
20190000718 A1 | Jan 2019 | US |